Principal - The Moran Company
Clare Mamerow has more than 20 years of experience in healthcare policy analysis and helping clients strategize and advocate for inpatient reimbursement solutions for a range of drugs, devices, and diagnostic tests.
She led the inpatient hospital team at The Moran Company (TMC), now an HMA Company, where she assisted clients with numerous New Technology Add-on Payment (NTAP) applications and helped model a new diagnosis-related group (DRG) for Chimeric antigen receptor T cells (CAR T) therapies.
In addition, she worked with other clients to provide analyses to support their requests for DRG reassignment and policy changes to support low-volume therapies after NTAP designation expires. She has performed in-depth analyses of the Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) competitive bidding program and was involved in research efforts to bundle post-acute services, as required by the Affordable Care Act.
Clare previously served as legislative counsel for a small lobbying firm specializing in healthcare and human rights issues. She was previously a senior health policy analyst with the Government Accountability Office (GAO) where she focused on the impacts of private long-term care insurance on Medicaid, and the Department of Veterans Affairs efforts to realign healthcare services.
Clare is a graduate of the University of Wisconsin Law School, with a Master of Public Administration and a bachelor’s degree from the University of Wisconsin, Madison. Clare is a member of the State Bar of Wisconsin.